In order to confirm that increased CDK4 and CDK6 activity results in RB hyperphosphorylation and leads to overexpression of HELLS, we treated all four human osteosarcoma cell lines with CDK4/6 inhibitor, palbociclib [33]. The gene discussed is CDK6; the disease is osteosarcoma.